![Neil Josephson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Neil Josephson
Technik-/Wissenschafts-/F&E-Leiter bei
IAMBIC THERAPEUTICS, INC.
Vermögen: 1 Mio $ am 30.09.2026
Profil
Dr. Neil Josephson, MD, is a Chief Medical Officer at Iambic Therapeutics, Inc. and an Associate Professor-Medicine at Bloodworks Northwest.
Dr. Josephson was previously employed as a Chief Medical Officer by Zymeworks BC, Inc., a Chief Medical Officer by Zymeworks, Inc., and a Vice President-Clinical Development by Seattle Genetics, Inc. He received his undergraduate degree from Dartmouth College and a doctorate degree from Columbia University Irving Medical Center.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.10.2026 | 71 459 ( 0,15 % ) | 1 Mio $ | 30.09.2026 |
Aktive Positionen von Neil Josephson
| Unternehmen | Position | Beginn |
|---|---|---|
| IAMBIC THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2024 |
Bloodworks Northwest
 Bloodworks Northwest Medical/Nursing ServicesHealth Services Provides Blood and tissue services | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Neil Josephson
| Unternehmen | Position | Ende |
|---|---|---|
| ZYMEWORKS INC. | Technik-/Wissenschafts-/F&E-Leiter | 03.01.2023 |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2023 |
| SEAGEN INC. | Corporate Officer/Principal | 01.01.2019 |
Ausbildung von Neil Josephson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
59
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cancer medicines | Health Technology |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Health Technology |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bloodworks Northwest
Bloodworks Northwest Medical/Nursing ServicesHealth Services Provides Blood and tissue services | Health Services |
Columbia University Medical Center
 Columbia University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Entos, Inc.
 Entos, Inc. BiotechnologyHealth Technology Operates as a clinical-stage life sciences and technology company advancing novel medicines using its AI-driven platform | Health Technology |
Zymeworks, Inc.
 Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
